ZOSTAVAX II
MERCK CANADA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ZOSTAVAX II discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ZOSTAVAX II 19400PFU has been permanently discontinued (last updated October 15, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ZOSTAVAX II not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02375516
Strength
19400PFU
Dosage Form
POWDER FOR SUSPENSION
Route
SUBCUTANEOUS
Active Ingredient
VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
See all VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED products →Compare with another product →
Shortage History
Business reasons
Demand increase for the drug.
Other Products from MERCK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 00782327
10MG · DIN 02483513
15MG · DIN 02483521
20MG · DIN 02483548
100MG · DIN 02451816
50MG · DIN 02244265
70MG · DIN 02244266
DIN 02549891
DIN 02482592
200MG · DIN 02387174
0.05% · DIN 00862975
0.05% · DIN 00688622